12:00 AM
 | 
Jan 05, 2015
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Centanafadine: Clinical trial data

Top-line data from a 5-arm, crossover, placebo- and active-controlled human abuse liability study in recreational stimulant users showed that single doses of 400 and 800 mg centanafadine immediate release (IR) led to an acute onset of...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >